Smaller Mean LDL Particle Size and Higher Proportion of Small Dense LDL in Korean Type 2 Diabetic Patients

다국어 초록 (Multilingual Abstract)

Background: Small dense low density lipoprotein (sdLDL) has recently emerged as an important risk factor of coronary heart disease.
Methods: The mean LDL particle size was measured in 203 patients with type 2 diabetes mellitus (T2DM) and 212 matched subjects without diabetes using polyacrylamide tube gel electrophoresis. Major vascular complications were defined as stroke, angiographically-documented coronary artery disease or a myocardial infarction. Peripheral vascular stenosis, carotid artery stenosis (≥50% in diameter) or carotid artery plaque were considered minor vascular complications. Overall vascular complications included both major and minor vascular complications.
Results: Diabetic patients had significantly smaller mean-LDL particle size (26.32 nm vs. 26.49 nm) and a higher percentage of sdLDL to total LDL compared to those of subjects without diabetes (21.39% vs. 6.34%). The independent predictors of sdLDL in this study were serum triglyceride level and body mass index (odds ratio [OR], 1.020 with P<0.001 and OR 1.152 with P<0.027, respectively). However, no significant correlations were found between sdLDL and major vascular complications (P=0.342), minor vascular complications (P=0.573) or overall vascular complications (P=0.262) in diabetic subjects.
Conclusion: Diabetic patients had a smaller mean-LDL particle size and higher proportion of sdLDL compared to those of subjects without diabetes. Obese diabetic patients with hypertriglyceridemia have an increased risk for atherogenic small dense LDL. However, we could not verify an association between LDL particle size and vascular complications in this study.

참고문헌 (Reference)

1 Nielsen LB, "Transfer of low density lipoprotein into the arterial wall and risk of atherosclerosis" 123 : 1-15, 1996

2 Lamarche B, "The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects" 25 : 199-211, 1999

3 Hulthe J, "The metabolic syndrome, LDL particle size, and atherosclerosis: the Atherosclerosis and Insulin Resistance (AIR) study" 20 : 2140-2147, 2000

4 Ip S, "Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes" 150 : 474-484, 2009

5 Lamarche B, "Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study" 95 : 69-75, 1997

6 Galeano NF, "Small dense low density lipoprotein has increased affinity for LDL receptor-independent cell surface binding sites: a potential mechanism for increased atherogenicity" 39 : 1263-1273, 1998

7 Yoon Y, "Significance of small dense low-density lipoproteins as coronary risk factor in diabetic and non-diabetic Korean populations" 43 : 431-437, 2005

8 권성우, "Significance of Small Dense Low-Density Lipoprotein as a Risk Factor for Coronary Artery Disease and Acute Coronary Syndrome" 연세대학교의과대학 47 (47): 405-414, 2006

9 Rizzo M, "Should we measure routinely the LDL peak particle size" 107 : 166-170, 2006

10 Suehiro T, "Relationship of low-density lipoprotein particle size to plasma lipoproteins, obesity, and insulin resistance in Japanese men" 18 : 333-338, 1995

11 Park JS, "Relationship of low-density lipoprotein particle size to insulin resistance and intima-media thickness in nondiabetic Koreans" 55 : 1610-1615, 2006

12 Rosenson RS, "Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial" 90 : 89-94, 2002

13 Kannel WB, "Range of serum cholesterol values in the population developing coronary artery disease" 76 : 69-77, 1995

14 Kolovou GD, "Pathophysiology of dyslipidaemia in the metabolic syndrome" 81 : 358-366, 2005

15 Miller WM, "Obesity and lipids" 7 : 465-470, 2005

16 Lee W, "Low-density lipoprotein subclass and its correlating factors in diabetics" 36 : 657-661, 2003

17 Kang HS, "Low-density lipoprotein particle size, central obesity, cardiovascular fitness, and insulin resistance syndrome markers in obese youths" 26 : 1030-1035, 2002

18 Festa A, "Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study" 19 : 605-610, 1999

19 Toyota Y, "Low density lipoprotein (LDL) binding affinity for the LDL receptor in hyperlipoproteinemia" 147 : 77-86, 1999

20 Haffner SM, "LDL size in African Americans, Hispanics, and non-Hispanic whites: the insulin resistance atherosclerosis study" 19 : 2234-2240, 1999

21 Lahdenpera S, "LDL particle size in mildly hypertriglyceridemic subjects: no relation to insulin resistance or diabetes" 113 : 227-236, 1995

22 Campos H, "LDL particle size distribution. Results from the Framingham Offspring Study" 12 : 1410-1419, 1992

23 Anber V, "Interaction of very-low-density, intermediate-density, and lowdensity lipoproteins with human arterial wall proteoglycans" 17 : 2507-2514, 1997

24 Li J, "Hypertriglyceridemia characterized by low-density lipoprotein phenotype and lipoprotein lipase gene mutation" 38 : 1263-1270, 2000

25 Gazi IF, "Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in women" 24 : 223-230, 2008

26 Lamarche B, "Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease" 279 : 1955-1961, 1998

27 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, "Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)" 285 : 2486-2497, 2001

28 Krauss RM, "Dietary and genetic probes of atherogenic dyslipidemia" 25 : 2265-2272, 2005

29 Krauss RM, "Dietary and genetic effects on low-density lipoprotein heterogeneity" 21 : 283-295, 2001

30 Stamler J, "Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial" 16 : 434-444, 1993

31 Hoefner DM, "Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System" 47 : 266-274, 2001

32 Krauss RM, "Dense low density lipoproteins and coronary artery disease" 75 : 53-57, 1995

33 American Diabetes Association, "Consensus development conference on the diagnosis of coronary heart disease in people with diabetes" 21 : 1551-1559, 1998

34 Austin MA, "Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance" 5 : 395-403, 1994

35 Austin MA, "Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk" 82 : 495-506, 1990

36 Krauss RM, "Atherogenic lipoprotein phenotype and diet-gene interactions" 131 : 340-343, 2001

37 Gardner CD, "Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women" 276 : 875-881, 1996

38 Maki KC, "Association between elevated plasma fibrinogen and the small, dense low-density lipoprotein phenotype among postmenopausal women" 85 : 451-456, 2000

39 Packard CJ, "Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions" 41 : 305-318, 2000

40 Stampfer MJ, "A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction" 276 : 882-888, 1996